相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study
Jia Fang et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)
Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model
Hong-Ling Peng et al.
CHINESE MEDICAL JOURNAL (2015)
Thalidomide in angiodysplasia-related bleeding
J. P. Boey et al.
INTERNAL MEDICINE JOURNAL (2015)
Follow-up of Thalidomide treatment in patients with Hereditary Haemorrhagic Telangiectasia
A. E. Hosman et al.
RHINOLOGY (2015)
Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study
Rosangela Invernizzi et al.
LANCET HAEMATOLOGY (2015)
The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia
Christian A. Merlo et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2014)
Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide
Massimo Franchini et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia
Andrea Penaloza et al.
BLOOD COAGULATION & FIBRINOLYSIS (2011)
Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
Franck Lebrin et al.
NATURE MEDICINE (2010)
Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy
Marianna Colagrande et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy
Vinay Chaudhry et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2008)
Emergencies in hereditary haemorrhagic telangiectasia
M Gallitelli et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2006)
Thalidomide as a novel therapeutic agent: new uses for an old product
SK Teo et al.
DRUG DISCOVERY TODAY (2005)
Health-related quality of life in a rare disease:: Hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber Disease
G Pasculli et al.
QUALITY OF LIFE RESEARCH (2004)
分享论文
